Endocytic regulation of cytokine receptor signaling

Cytokine and Growth Factor Reviews

Volumn 32, Issue , 2016, Pages 63-73

  Cendrowski, Jaroslaw ^a   Mamińska, Agnieszka ^a   Miaczynska, Marta ^a  

^a INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Clathrin; Cytokine receptor; Dynamin; Endocytosis; Endosome; Interferon; Interleukin; Internalization; Jak; Lymphotoxin; Multivesicular body; NF B; Signaling; STAT; TNF; Trafficking

Indexed keywords

CYTOKINE RECEPTOR; DEATH RECEPTOR; GLYCOPROTEIN GP 130; INTERFERON RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

BETA CHAIN; ENDOCYTOSIS; ENDOSOME; HUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; METABOLISM; PROTEIN SUBUNIT;

ENDOCYTOSIS; HUMANS; PROTEIN SUBUNITS; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION;

EID: 84978977520     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2016.07.002     Document Type: Short Survey

References (153)

1. [1] Barbieri, E., Di Fiore, P.P., Sigismund, S., Endocytic control of signaling at the plasma membrane. Curr. Opin. Cell Biol. 39 (2016), 21–27.
2. [2] Tomas, A., Futter, C.E., Eden, E.R., EGF receptor trafficking: consequences for signaling and cancer. Trends Cell Biol. 24 (2014), 26–34.
3. [3] Marchese, A., Endocytic trafficking of chemokine receptors. Curr. Opin. Cell Biol. 27 (2014), 72–77.
4. [4] Miaczynska, M., Effects of membrane trafficking on signaling by receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol., 5, 2013, a009035.
5. [5] Tsvetanova, N.G., Irannejad, R., von Zastrow, M., G protein-coupled receptor (GPCR) signaling via heterotrimeric G proteins from endosomes. J. Biol. Chem. 290 (2015), 6689–6696.
6. [6] McMahon, H.T., Boucrot, E., Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12 (2011), 517–533.
7. [7] Kirchhausen, T., Owen, D., Harrison, S.C., Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. Cold Spring Harb. Perspect. Biol., 6, 2014, a016725.
8. [8] Cocucci, E., Gaudin, R., Kirchhausen, T., Dynamin recruitment and membrane scission at the neck of a clathrin-coated pit. Mol. Biol. Cell 25 (2014), 3595–3609.
9. [9] Mayor, S., Parton, R.G., Donaldson, J.G., Clathrin-independent pathways of endocytosis. Cold Spring Harb. Perspect. Biol., 6, 2014.
10. [10] Drevot, P., Langlet, C., Guo, X.J., Bernard, A.M., Colard, O., Chauvin, J.P., et al. TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. EMBO J. 21 (2002), 1899–1908.
11. [11] Parton, R.G., Hancock, J.F., Lipid rafts and plasma membrane microorganization: insights from Ras. Trends Cell Biol. 14 (2004), 141–147.
12. [12] Bastiani, M., Parton, R.G., Caveolae at a glance. J. Cell Sci. 123 (2010), 3831–3836.
13. [13] Lamaze, C., Dujeancourt, A., Baba, T., Lo, C.G., Benmerah, A., Dautry-Varsat, A., Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell 7 (2001), 661–671.
14. [14] Renard, H.F., Simunovic, M., Lemiere, J., Boucrot, E., Garcia-Castillo, M.D., Arumugam, S., et al. Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis. Nature 517 (2015), 493–496.
15. [15] Boucrot, E., Ferreira, A.P., Almeida-Souza, L., Debard, S., Vallis, Y., Howard, G., et al. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature 517 (2015), 460–465.
16. [16] Sabharanjak, S., Sharma, P., Parton, R.G., Mayor, S., GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev. Cell 2 (2002), 411–423.
17. [17] Kirkham, M., Fujita, A., Chadda, R., Nixon, S.J., Kurzchalia, T.V., Sharma, D.K., et al. Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J. Cell Biol. 168 (2005), 465–476.
18. [18] Lakshminarayan, R., Wunder, C., Becken, U., Howes, M.T., Benzing, C., Arumugam, S., et al. Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers. Nat. Cell Biol. 16 (2014), 595–606.
19. [19] Kumari, S., Mayor, S., ARF1 is directly involved in dynamin-independent endocytosis. Nat. Cell Biol. 10 (2008), 30–41.
20. [20] Egami, Y., Taguchi, T., Maekawa, M., Arai, H., Small, Araki N., GTPases and phosphoinositides in the regulatory mechanisms of macropinosome formation and maturation. Front. Physiol., 5, 2014, 374.
21. [21] Bucci, C., Parton, R.G., Mather, I.H., Stunnenberg, H., Simons, K., Hoflack, B., et al. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70 (1992), 715–728.
22. [22] Miaczynska, M., Christoforidis, S., Giner, A., Shevchenko, A., Uttenweiler-Joseph, S., Habermann, B., et al. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116 (2004), 445–456.
23. [23] Kalaidzidis, I., Miaczynska, M., Brewinska-Olchowik, M., Hupalowska, A., Ferguson, C., Parton, R.G., et al. APPL endosomes are not obligatory endocytic intermediates but act as stable cargo-sorting compartments. J. Cell Biol. 211 (2015), 123–144.
24. [24] van der Sluijs, P., Hull, M., Webster, P., Male, P., Goud, B., Mellman, I., The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell 70 (1992), 729–740.
25. [25] Ullrich, O., Reinsch, S., Urbe, S., Zerial, M., Parton, R.G., Rab11 regulates recycling through the pericentriolar recycling endosome. J. Cell Biol. 135 (1996), 913–924.
26. [26] Zerial, M., McBride, H., Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2 (2001), 107–117.
27. [27] Raiborg, C., Stenmark, H., Hrs and endocytic sorting of ubiquitinated membrane proteins. Cell Struct. Funct. 27 (2002), 403–408.
28. [28] Bache, K.G., Raiborg, C., Mehlum, A., Stenmark, H., STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes. J. Biol. Chem. 278 (2003), 12513–12521.
29. [29] Raiborg, C., Rusten, T.E., Stenmark, H., Protein sorting into multivesicular endosomes. Curr. Opin. Cell Biol. 15 (2003), 446–455.
30. [30] Gruenberg, J., The endocytic pathway: a mosaic of domains. Nat. Rev. Mol. Cell Biol. 2 (2001), 721–730.
31. [31] Rink, J., Ghigo, E., Kalaidzidis, Y., Zerial, M., Rab conversion as a mechanism of progression from early to late endosomes. Cell 122 (2005), 735–749.
32. [32] Luzio, J.P., Rous, B.A., Bright, N.A., Pryor, P.R., Mullock, B.M., Piper, R.C., Lysosome-endosome fusion and lysosome biogenesis. J. Cell Sci. 113:Pt. 9 (2000), 1515–1524.
33. [33] Luzio, J.P., Pryor, P.R., Bright, N.A., Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol. 8 (2007), 622–632.
34. [34] Luzio, J.P., Hackmann, Y., Dieckmann, N.M., Griffiths, G.M., The biogenesis of lysosomes and lysosome-related organelles. Cold Spring Harb. Perspect. Biol., 6, 2014.
35. [35] Yu, A., Rual, J.F., Tamai, K., Harada, Y., Vidal, M., He, X., et al. Association of dishevelled with the clathrin AP-2 adaptor is required for frizzled endocytosis and planar cell polarity signaling. Dev. Cell 12 (2007), 129–141.
36. [36] Oakley, R.H., Laporte, S.A., Holt, J.A., Barak, L.S., Caron, M.G., Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 274 (1999), 32248–32257.
37. [37] DeFea, K.A., Zalevsky, J., Thoma, M.S., Dery, O., Mullins, R.D., Bunnett, N.W., Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148 (2000), 1267–1281.
38. [38] DeWire, S.M., Ahn, S., Lefkowitz, R.J., Shenoy, S.K., Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69 (2007), 483–510.
39. [39] Irannejad, R., Tomshine, J.C., Tomshine, J.R., Chevalier, M., Mahoney, J.P., Steyaert, J., et al. Conformational biosensors reveal GPCR signalling from endosomes. Nature 495 (2013), 534–538.
40. [40] Gaullier, J.M., Simonsen, A., D'Arrigo, A., Bremnes, B., Stenmark, H., Aasland, R., FYVE fingers bind PtdIns(3)P. Nature 394 (1998), 432–433.
41. [41] Hayes, S., Chawla, A., Corvera, S., TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J. Cell Biol. 158 (2002), 1239–1249.
42. [42] Chen, Y.G., Wang, Z., Ma, J., Zhang, L., Lu, Z., Endofin, a FYVE domain protein, interacts with Smad4 and facilitates transforming growth factor-beta signaling. J. Biol. Chem. 282 (2007), 9688–9695.
43. [43] Nakamura, N., Lill, J.R., Phung, Q., Jiang, Z., Bakalarski, C., de Maziere, A., et al. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 509 (2014), 240–244.
44. [44] Sigismund, S., Argenzio, E., Tosoni, D., Cavallaro, E., Polo, S., Di Fiore, P.P., Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev. Cell 15 (2008), 209–219.
45. [45] Li, J., Yin, Q., Wu, H., Structural basis of signal transduction in the TNF receptor superfamily. Adv. Immunol. 119 (2013), 135–153.
46. [46] Micheau, O., Tschopp, J., Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 (2003), 181–190.
47. [47] Schneider-Brachert, W., Heigl, U., Ehrenschwender, M., Membrane trafficking of death receptors: implications on signalling. Int. J. Mol. Sci. 14 (2013), 14475–14503.
48. [48] Tchikov, V., Bertsch, U., Fritsch, J., Edelmann, B., Schutze, S., Subcellular compartmentalization of TNF receptor-1 and CD95 signaling pathways. Eur. J. Cell Biol. 90 (2011), 467–475.
49. [49] Higuchi, M., Aggarwal, B.B., TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J. Immunol. 152 (1994), 3550–3558.
50. [50] Watanabe, N., Kuriyama, H., Sone, H., Neda, H., Yamauchi, N., Maeda, M., et al. Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line. J. Biol. Chem. 263 (1988), 10262–10266.
51. [51] Mosselmans, R., Hepburn, A., Dumont, J.E., Fiers, W., Galand, P., Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. J. Immunol. 141 (1988), 3096–3100.
52. [52] Legler, D.F., Micheau, O., Doucey, M.A., Tschopp, J., Bron, C., Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18 (2003), 655–664.
53. [53] D'Alessio, A., Al-Lamki, R.S., Bradley, J.R., Pober, J.S., Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am. J. Pathol. 166 (2005), 1273–1282.
54. [54] D'Alessio, A., Kluger, M.S., Li, J.H., Al-Lamki, R., Bradley, J.R., Pober, J.S., Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells. J. Biol. Chem. 285 (2010), 23868–23879.
55. [55] Bradley, J.R., Johnson, D.R., Pober, J.S., Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells. J. Immunol. 150 (1993), 5544–5555.
56. [56] Schneider-Brachert, W., Tchikov, V., Neumeyer, J., Jakob, M., Winoto-Morbach, S., Held-Feindt, J., et al. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21 (2004), 415–428.
57. [57] Choi, H., Nguyen, H.N., Lamb, F.S., Inhibition of endocytosis exacerbates TNF-alpha-induced endothelial dysfunction via enhanced JNK and p38 activation. Am. J. Physiol. Heart Circ. Physiol. 306 (2014), H1154–H1163.
58. [58] Schutze, S., Tchikov, V., Schneider-Brachert, W., Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat. Rev. Mol. Cell Biol. 9 (2008), 655–662.
59. [59] Neumeyer, J., Hallas, C., Merkel, O., Winoto-Morbach, S., Jakob, M., Thon, L., et al. TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase. Exp. Cell Res. 312 (2006), 2142–2153.
60. [60] Edelmann, B., Bertsch, U., Tchikov, V., Winoto-Morbach, S., Perrotta, C., Jakob, M., et al. Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J. 30 (2011), 379–394.
61. [61] Hupalowska, A., Miaczynska, M., The new faces of endocytosis in signaling. Traffic 13 (2012), 9–18.
62. [62] Sun, S., Zhou, X., Zhang, W., Gallick, G.E., Kuang, J., Unravelling the pivotal role of Alix in MVB sorting and silencing of the activated EGFR. Biochem. J. 466 (2015), 475–487.
63. [63] Sun, S., Zhou, X., Corvera, J., Gallick, G.E., Lin, S.-H., Kuang, J., ALG-2 activates the MVB sorting function of ALIX through relieving its intramolecular interaction. Cell Discov., 1, 2015, 15018.
64. [64] Bissig, C., Gruenberg, J., ALIX and the multivesicular endosome: ALIX in Wonderland. Trends Cell Biol. 24 (2014), 19–25.
65. [65] Falguieres, T., Luyet, P.P., Bissig, C., Scott, C.C., Velluz, M.C., Gruenberg, J., In vitro budding of intralumenal vesicles into late endosomes is regulated by Alix and Tsg101. Mol. Biol. Cell 19 (2008), 4942–4955.
66. [66] Mahul-Mellier, A.L., Strappazzon, F., Petiot, A., Chatellard-Causse, C., Torch, S., Blot, B., et al. Alix and ALG-2 are involved in tumor necrosis factor receptor 1-induced cell death. J. Biol. Chem. 283 (2008), 34954–34965.
67. [67] Algeciras-Schimnich, A., Shen, L., Barnhart, B.C., Murmann, A.E., Burkhardt, J.K., Peter, M.E., Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22 (2002), 207–220.
68. [68] Lee, K.H., Feig, C., Tchikov, V., Schickel, R., Hallas, C., Schutze, S., et al. The role of receptor internalization in CD95 signaling. EMBO J. 25 (2006), 1009–1023.
69. [69] Gajate, C., Mollinedo, F., Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling. Apoptosis 20 (2015), 584–606.
70. [70] Chakrabandhu, K., Herincs, Z., Huault, S., Dost, B., Peng, L., Conchonaud, F., et al. Palmitoylation is required for efficient Fas cell death signaling. EMBO J. 26 (2007), 209–220.
71. [71] Feig, C., Tchikov, V., Schutze, S., Peter, M.E., Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J. 26 (2007), 221–231.
72. [72] Parlato, S., Giammarioli, A.M., Logozzi, M., Lozupone, F., Matarrese, P., Luciani, F., et al. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19 (2000), 5123–5134.
73. [73] Chakrabandhu, K., Huault, S., Garmy, N., Fantini, J., Stebe, E., Mailfert, S., et al. The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand. Cell Death Differ. 15 (2008), 1824–1837.
74. [74] Rossin, A., Kral, R., Lounnas, N., Chakrabandhu, K., Mailfert, S., Marguet, D., et al. Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death. Exp. Cell Res. 316 (2010), 1513–1522.
75. [75] Iessi, E., Zischler, L., Etringer, A., Bergeret, M., Morle, A., Jacquemin, G., et al. Death receptor-Induced apoptosis signalling regulation by ezrin is cell type dependent and occurs in a DISC-Independent manner in colon cancer cells. PLoS One, 10, 2015, e0126526.
76. [76] Austin, C.D., Lawrence, D.A., Peden, A.A., Varfolomeev, E.E., Totpal, K., De Maziere, A.M., et al. Death-receptor activation halts clathrin-dependent endocytosis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 10283–10288.
77. [77] Kohlhaas, S.L., Craxton, A., Sun, X.M., Pinkoski, M.J., Cohen, G.M., Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J. Biol. Chem. 282 (2007), 12831–12841.
78. [78] Akazawa, Y., Mott, J.L., Bronk, S.F., Werneburg, N.W., Kahraman, A., Guicciardi, M.E., et al. Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. Gastroenterology 136 (2009), 2365–2376 e1–e7.
79. [79] Hayden, M.S., Ghosh, S., Regulation of NF-kappaB by TNF family cytokines. Semin. Immunol. 26 (2014), 253–266.
80. [80] Remouchamps, C., Boutaffala, L., Ganeff, C., Dejardin, E., Biology and signal transduction pathways of the Lymphotoxin-alphabeta/LTbetaR system. Cytokine Growth Factor Rev. 22 (2011), 301–310.
81. [81] VanArsdale, T.L., VanArsdale, S.L., Force, W.R., Walter, B.N., Mosialos, G., Kieff, E., et al. Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 2460–2465.
82. [82] Nakano, H., Oshima, H., Chung, W., Williams-Abbott, L., Ware, C.F., Yagita, H., et al. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J. Biol. Chem. 271 (1996), 14661–14664.
83. [83] Kim, Y.S., Nedospasov, S.A., Liu, Z.G., TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling. Mol. Cell. Biol. 25 (2005), 2130–2137.
84. [84] Ganeff, C., Remouchamps, C., Boutaffala, L., Benezech, C., Galopin, G., Vandepaer, S., et al. Induction of the alternative NF-kappaB pathway by lymphotoxin alphabeta (LTalphabeta) relies on internalization of LTbeta receptor. Mol. Cell. Biol. 31 (2011), 4319–4334.
85. [85] Maminska, A., Bartosik, A., Banach-Orlowska, M., Pilecka, I., Jastrzebski, K., Zdzalik-Bielecka, D., et al. ESCRT proteins restrict constitutive NF-kappaB signaling by trafficking cytokine receptors. Sci. Signal., 9, 2016, ra8.
86. [86] Zarnegar, B., He, J.Q., Oganesyan, G., Hoffmann, A., Baltimore, D., Cheng, G., Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 8108–8113.
87. [87] Elgueta, R., Benson, M.J., de Vries, V.C., Wasiuk, A., Guo, Y., Noelle, R.J., Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229 (2009), 152–172.
88. [88] Xia, M., Wang, Q., Zhu, H., Ma, J., Hou, M., Tang, Z., et al. Lipid rafts regulate cellular CD40 receptor localization in vascular endothelial cells. Biochem. Biophys. Res. Commun. 361 (2007), 768–774.
89. [89] Grassme, H., Jendrossek, V., Bock, J., Riehle, A., Gulbins, E., Ceramide-rich membrane rafts mediate CD40 clustering. J. Immunol. 168 (2002), 298–307.
90. [90] Vidalain, P.O., Azocar, O., Servet-Delprat, C., Rabourdin-Combe, C., Gerlier, D., Manie, S., CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J. 19 (2000), 3304–3313.
91. [91] Grassme, H., Bock, J., Kun, J., Gulbins, E., Clustering of CD40 ligand is required to form a functional contact with CD40. J. Biol. Chem. 277 (2002), 30289–30299.
92. [92] Hostager, B.S., Catlett, I.M., Bishop, G.A., Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J. Biol. Chem. 275 (2000), 15392–15398.
93. [93] Nadiri, A., Polyak, M.J., Jundi, M., Alturaihi, H., Reyes-Moreno, C., Hassan, G.S., et al. CD40 translocation to lipid rafts: signaling requirements and downstream biological events. Eur. J. Immunol. 41 (2011), 2358–2367.
94. [94] Chen, J., Chen, L., Wang, G., Tang, H., Cholesterol-dependent and -independent CD40 internalization and signaling activation in cardiovascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 2005–2013.
95. [95] Chen, Y., Chen, J., Xiong, Y., Da, Q., Xu, Y., Jiang, X., et al. Internalization of CD40 regulates its signal transduction in vascular endothelial cells. Biochem. Biophys. Res. Commun. 345 (2006), 106–117.
96. [96] Garlanda, C., Dinarello, C.A., Mantovani, A., The interleukin-1 family: back to the future. Immunity 39 (2013), 1003–1018.
97. [97] Mizel, S.B., Kilian, P.L., Lewis, J.C., Paganelli, K.A., Chizzonite, R.A., The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts. J. Immunol. 138 (1987), 2906–2912.
98. [98] Brissoni, B., Agostini, L., Kropf, M., Martinon, F., Swoboda, V., Lippens, S., et al. Intracellular trafficking of interleukin-1 receptor I requires Tollip. Curr. Biol. 16 (2006), 2265–2270.
99. [99] Blanco, A.M., Perez-Arago, A., Fernandez-Lizarbe, S., Guerri, C., Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. J. Neurochem. 106 (2008), 625–639.
100. [100] Hansen, B., Dittrich-Breiholz, O., Kracht, M., Windheim, M., Regulation of NF-kappaB-dependent gene expression by ligand-induced endocytosis of the interleukin-1 receptor. Cell. Signal. 25 (2013), 214–228.
101. [101] Windheim, M., Hansen, B., Interleukin-1-induced activation of the small GTPase Rac1 depends on receptor internalization and regulates gene expression. Cell. Signal. 26 (2014), 49–55.
102. [102] Li, Q., Harraz, M.M., Zhou, W., Zhang, L.N., Ding, W., Zhang, Y., et al. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol. Cell. Biol. 26 (2006), 140–154.
103. [103] Curtis, B.M., Widmer, M.B., deRoos, P., Qwarnstrom, E.E., IL-1 and its receptor are translocated to the nucleus. J. Immunol. 144 (1990), 1295–1303.
104. [104] Weitzmann, M.N., Savage, N., Nuclear internalisation and DNA binding activities of interleukin-1, interleukin-1 receptor and interleukin-1/receptor complexes. Biochem. Biophys. Res. Commun. 187 (1992), 1166–1171.
105. [105] Bol, G., Kreuzer, O.J., Brigelius-Flohe, R., Translocation of the interleukin-1 receptor-associated kinase-1 (IRAK-1) into the nucleus. FEBS Lett. 477 (2000), 73–78.
106. [106] Bavelloni, A., Santi, S., Sirri, A., Riccio, M., Faenza, I., Zini, N., et al. Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells. J. Cell Sci. 112:Pt. 5 (1999), 631–640.
107. [107] Gresnigt, M.S., van de Veerdonk, F.L., Biology of IL-36 cytokines and their role in disease. Semin. Immunol. 25 (2013), 458–465.
108. [108] Saha, S.S., Singh, D., Raymond, E.L., Ganesan, R., Caviness, G., Grimaldi, C., et al. Signal transduction and intracellular trafficking by the interleukin 36 receptor. J. Biol. Chem. 290 (2015), 23997–24006.
109. [109] Waldmann, T.A., The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol. Res. 3 (2015), 219–227.
110. [110] Rochman, Y., Spolski, R., Leonard, W.J., New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9 (2009), 480–490.
111. [111] Meazza, R., Azzarone, B., Orengo, A.M., Ferrini, S., Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy. J. Biomed. Biotechnol., 2011, 2011, 861920.
112. [112] Morelon, E., Dautry-Varsat, A., Endocytosis of the common cytokine receptor gammac chain: identification of sequences involved in internalization and degradation. J. Biol. Chem. 273 (1998), 22044–22051.
113. [113] Sauvonnet, N., Dujeancourt, A., Dautry-Varsat, A., Cortactin and dynamin are required for the clathrin-independent endocytosis of gammac cytokine receptor. J. Cell Biol. 168 (2005), 155–163.
114. [114] Duprez, V., Dautry-Varsat, A., Receptor-mediated endocytosis of interleukin 2 in a human tumor T cell line. Degradation of interleukin 2 and evidence for the absence of recycling of interleukin receptors. J. Biol. Chem. 261 (1986), 15450–15454.
115. [115] Duprez, V., Cornet, V., Dautry-Varsat, A., Down-regulation of high affinity interleukin 2 receptors in a human tumor T cell line. Interleukin 2 increases the rate of surface receptor decay. J. Biol. Chem. 263 (1988), 12860–12865.
116. [116] Yu, A., Olosz, F., Choi, C.Y., Malek, T.R., Efficient internalization of IL-2 depends on the distal portion of the cytoplasmic tail of the IL-2R common gamma-chain and a lymphoid cell environment. J. Immunol. 165 (2000), 2556–2562.
117. [117] Hemar, A., Subtil, A., Lieb, M., Morelon, E., Hellio, R., Dautry-Varsat, A., Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J. Cell Biol. 129 (1995), 55–64.
118. [118] Subtil, A., Hemar, A., Dautry-Varsat, A., Rapid endocytosis of interleukin 2 receptors when clathrin-coated pit endocytosis is inhibited. J. Cell Sci. 107:Pt. 12 (1994), 3461–3468.
119. [119] Basquin, C., Sauvonnet, N., Phosphoinositide 3-kinase at the crossroad between endocytosis and signaling of cytokine receptors. Commun. Integr. Biol., 6, 2013, e24243.
120. [120] Basquin, C., Malarde, V., Mellor, P., Anderson, D.H., Meas-Yedid, V., Olivo-Marin, J.C., et al. The signalling factor PI3K is a specific regulator of the clathrin-independent dynamin-dependent endocytosis of IL-2 receptors. J. Cell Sci. 126 (2013), 1099–1108.
121. [121] Grassart, A., Dujeancourt, A., Lazarow, P.B., Dautry-Varsat, A., Sauvonnet, N., Clathrin-independent endocytosis used by the IL-2 receptor is regulated by Rac1, Pak1 and Pak2. EMBO Rep. 9 (2008), 356–362.
122. [122] Basquin, C., Trichet, M., Vihinen, H., Malarde, V., Lagache, T., Ripoll, L., et al. Membrane protrusion powers clathrin-independent endocytosis of interleukin-2 receptor. EMBO J. 34 (2015), 2147–2161.
123. [123] Gandhi, H., Worch, R., Kurgonaite, K., Hintersteiner, M., Schwille, P., Bokel, C., et al. Dynamics and interaction of interleukin-4 receptor subunits in living cells. Biophys. J. 107 (2014), 2515–2527.
124. [124] Kurgonaite, K., Gandhi, H., Kurth, T., Pautot, S., Schwille, P., Weidemann, T., et al. Essential role of endocytosis for interleukin-4-receptor-mediated JAK/STAT signalling. J. Cell Sci. 128 (2015), 3781–3795.
125. [125] Geijsen, N., Koenderman, L., Coffer, P.J., Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. Cytokine Growth Factor Rev. 12 (2001), 19–25.
126. [126] de Groot, R.P., Coffer, P.J., Koenderman, L., Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell. Signal. 10 (1998), 619–628.
127. [127] Sato, N., Caux, C., Kitamura, T., Watanabe, Y., Arai, K., Banchereau, J., et al. Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 82 (1993), 752–761.
128. [128] Martinez-Moczygemba, M., Huston, D.P., Lei, J.T., JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization. J. Leukoc. Biol. 81 (2007), 1137–1148.
129. [129] Lei, J.T., Martinez-Moczygemba, M., Separate endocytic pathways regulate IL-5 receptor internalization and signaling. J. Leukoc. Biol. 84 (2008), 499–509.
130. [130] Lei, J.T., Mazumdar, T., Martinez-Moczygemba, M., Three lysine residues in the common beta chain of the interleukin-5 receptor are required for Janus kinase (JAK)-dependent receptor ubiquitination, endocytosis, and signaling. J. Biol. Chem. 286 (2011), 40091–40103.
131. [131] Martinez-Moczygemba, M., Huston, D.P., Proteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitization. J. Clin. Investig. 108 (2001), 1797–1806.
132. [132] Wang, X., Lupardus, P., Laporte, S.L., Garcia, K.C., Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 27 (2009), 29–60.
133. [133] Wolf, J., Rose-John, S., Garbers, C., Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 70 (2014), 11–20.
134. [134] Kim, H., Baumann, H., Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Mol. Cell. Biol. 19 (1999), 5326–5338.
135. [135] Giordano, V., De Falco, G., Chiari, R., Quinto, I., Pelicci, P.G., Bartholomew, L., et al. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J. Immunol. 158 (1997), 4097–4103.
136. [136] Heinrich, P.C., Behrmann, I., Muller-Newen, G., Schaper, F., Graeve, L., Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:Pt. 2 (1998), 297–314.
137. [137] Thiel, S., Dahmen, H., Martens, A., Muller-Newen, G., Schaper, F., Heinrich, P.C., et al. Constitutive internalization and association with adaptor protein-2 of the interleukin-6 signal transducer gp130. FEBS Lett. 441 (1998), 231–234.
138. [138] Thiel, S., Behrmann, I., Dittrich, E., Muys, L., Tavernier, J., Wijdenes, J., et al. Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochem. J. 330:Pt. 1 (1998), 47–54.
139. [139] Tanaka, Y., Tanaka, N., Saeki, Y., Tanaka, K., Murakami, M., Hirano, T., et al. c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol. Cell. Biol. 28 (2008), 4805–4818.
140. [140] Dittrich, E., Haft, C.R., Muys, L., Heinrich, P.C., Graeve, L., A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor. J. Biol. Chem. 271 (1996), 5487–5494.
141. [141] Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P.C., Binder, B.R., Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272 (1997), 28563–28567.
142. [142] Sehgal, P.B., Guo, G.G., Shah, M., Kumar, V., Patel, K., Cytokine signaling: STATS in plasma membrane rafts. J. Biol. Chem. 277 (2002), 12067–12074.
143. [143] Yamaguchi, T., Naruishi, K., Arai, H., Nishimura, F., Takashiba, S., IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts. J. Cell. Physiol. 217 (2008), 423–432.
144. [144] German, C.L., Sauer, B.M., Howe, C.L., The STAT3 beacon: IL-6 recurrently activates STAT 3 from endosomal structures. Exp. Cell Res. 317 (2011), 1955–1969.
145. [145] Parmar, S., Platanias, L.C., Interferons: mechanisms of action and clinical applications. Curr. Opin. Oncol. 15 (2003), 431–439.
146. [146] Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H., Schreiber, R.D., How cells respond to interferons. Annu. Rev. Biochem. 67 (1998), 227–264.
147. [147] Pestka, S., Kotenko, S.V., Muthukumaran, G., Izotova, L.S., Cook, J.R., Garotta, G., The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 8 (1997), 189–206.
148. [148] Takaoka, A., Mitani, Y., Suemori, H., Sato, M., Yokochi, T., Noguchi, S., et al. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 288 (2000), 2357–2360.
149. [149] Marchetti, M., Monier, M.N., Fradagrada, A., Mitchell, K., Baychelier, F., Eid, P., et al. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol. Biol. Cell 17 (2006), 2896–2909.
150. [150] Subramaniam, P.S., Johnson, H.M., Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1alpha. J. Immunol. 169 (2002), 1959–1969.
151. [151] Zheng, H., Qian, J., Baker, D.P., Fuchs, S.Y., Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor. J. Biol. Chem. 286 (2011), 35733–35741.
152. [152] Kumar, K.G., Barriere, H., Carbone, C.J., Liu, J., Swaminathan, G., Xu, P., et al. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J. Cell Biol. 179 (2007), 935–950.
153. [153] Ahmed, C.M., Burkhart, M.A., Mujtaba, M.G., Subramaniam, P.S., Johnson, H.M., The role of IFNgamma nuclear localization sequence in intracellular function. J. Cell Sci. 116 (2003), 3089–3098.